(NASDAQ: IOBT) Io Biotech's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 113.87%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 23.2%.
Io Biotech's revenue in 2026 is $0.On average, 8 Wall Street analysts forecast IOBT's revenue for 2026 to be $330,748,827, with the lowest IOBT revenue forecast at $0, and the highest IOBT revenue forecast at $1,021,529,659. On average, 8 Wall Street analysts forecast IOBT's revenue for 2027 to be $2,154,867,818, with the lowest IOBT revenue forecast at $0, and the highest IOBT revenue forecast at $4,627,245,876.
In 2028, IOBT is forecast to generate $963,323,046 in revenue, with the lowest revenue forecast at $0 and the highest revenue forecast at $1,909,738,113.